Quick Answer
Allarity Therapeutics, Inc. reported Total Assets of $18.26 million for the year ending 2025.
- Allarity Therapeutics, Inc. showed a decrease of -19.4% in Total Assets from 2024 to 2025.
- This data is from Allarity Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $36.99 million | Q1 2022: $31.29 million | Q2 2022: $23.23 million | Q3 2022: $18.13 million | Q1 2023: $12.70 million | Q2 2023: $13.43 million | Q3 2023: $13.88 million | Q1 2024: $11.97 million | Q2 2024: $30.88 million | Q3 2024: $20.38 million | Q1 2025: $29.73 million | Q2 2025: $21.21 million | Q3 2025: $20.80 million.
- Over the full 6 years of available data (2020 to 2025), Allarity Therapeutics, Inc.'s Total Assets has declined by 45.3%.
- Historical annual values: Fiscal year 2025: $18.26 million | Fiscal year 2024: $22.65 million | Fiscal year 2023: $11.86 million | Fiscal year 2022: $14.54 million | Fiscal year 2021: $49.63 million | Fiscal year 2020: $33.40 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: